A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results (Q36016617)

11 August 2017

A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results (English)

1 reference

11 August 2017

9

Nicolas Wentzensen

1 reference

11 August 2017

1

Mark Schiffman

1 reference

11 August 2017

4

Philip E Castle

1 reference

11 August 2017

Laurence M Vaughan

2

1 reference

11 August 2017

Tina R Raine-Bennett

3

1 reference

11 August 2017

Hormuzd A Katki

5

1 reference

11 August 2017

Julia C Gage

6

1 reference

11 August 2017

Barbara Fetterman

7

1 reference

11 August 2017

Brian Befano

8

1 reference

11 August 2017

language of work or name

English

0 references

publication date

3 July 2015

1 reference

11 August 2017

1 reference

11 August 2017

138

1 reference

11 August 2017

3

1 reference

11 August 2017

573-578

1 reference

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

Comparing the performance of six human papillomavirus tests in a screening population

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

Evaluation of a new DNA test for detection of carcinogenic human papillomavirus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

A review of human carcinogens--Part B: biological agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

Second edition of 'The Bethesda System for reporting cervical cytology' - atlas, website, and Bethesda interobserver reproducibility project

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4556538

Human papillomavirus and cervical cancer

23 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.06.040

10.1016/J.YGYNO.2015.06.040

7 January 2021

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

26148763

1 reference